1-1 of 1
Michael A Gorin, BS
Close
Sort by
Journal Articles

Facilitating Engraftment After MHC-Matched, Allogeneic BMT by IL-2 / Anti IL-2 Complex Treatment Requires Targeting CD25 On, and Activation in Situ of, Residual CD4 Tregs.

Alwi Shatry, Ph.D., Michael A Gorin, BS, Jackelin G Chirinos, BS, Robert B. Levy, PhD
Journal: Blood
Blood (2009) 114 (22): 66.
https://doi.org/10.1182/blood.V114.22.66.66
Published: 2009